1. Home
  2. WYFI vs SYRE Comparison

WYFI vs SYRE Comparison

Compare WYFI & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WYFI
  • SYRE
  • Stock Information
  • Founded
  • WYFI 2023
  • SYRE 2013
  • Country
  • WYFI United States
  • SYRE United States
  • Employees
  • WYFI N/A
  • SYRE N/A
  • Industry
  • WYFI Finance: Consumer Services
  • SYRE Biotechnology: Pharmaceutical Preparations
  • Sector
  • WYFI Finance
  • SYRE Health Care
  • Exchange
  • WYFI Nasdaq
  • SYRE Nasdaq
  • Market Cap
  • WYFI 1.1B
  • SYRE 1.1B
  • IPO Year
  • WYFI 2025
  • SYRE 2016
  • Fundamental
  • Price
  • WYFI $18.13
  • SYRE $23.71
  • Analyst Decision
  • WYFI Strong Buy
  • SYRE Strong Buy
  • Analyst Count
  • WYFI 6
  • SYRE 5
  • Target Price
  • WYFI $33.33
  • SYRE $55.75
  • AVG Volume (30 Days)
  • WYFI 1.1M
  • SYRE 741.8K
  • Earning Date
  • WYFI 11-13-2025
  • SYRE 11-04-2025
  • Dividend Yield
  • WYFI N/A
  • SYRE N/A
  • EPS Growth
  • WYFI N/A
  • SYRE N/A
  • EPS
  • WYFI N/A
  • SYRE N/A
  • Revenue
  • WYFI $70,202,034.00
  • SYRE N/A
  • Revenue This Year
  • WYFI $78.72
  • SYRE N/A
  • Revenue Next Year
  • WYFI $135.96
  • SYRE N/A
  • P/E Ratio
  • WYFI N/A
  • SYRE N/A
  • Revenue Growth
  • WYFI N/A
  • SYRE N/A
  • 52 Week Low
  • WYFI $14.01
  • SYRE $10.91
  • 52 Week High
  • WYFI $40.75
  • SYRE $33.47
  • Technical
  • Relative Strength Index (RSI)
  • WYFI N/A
  • SYRE 60.31
  • Support Level
  • WYFI N/A
  • SYRE $21.63
  • Resistance Level
  • WYFI N/A
  • SYRE $24.19
  • Average True Range (ATR)
  • WYFI 0.00
  • SYRE 1.33
  • MACD
  • WYFI 0.00
  • SYRE -0.26
  • Stochastic Oscillator
  • WYFI 0.00
  • SYRE 67.01

About WYFI WhiteFiber Inc. Ordinary Shares

Whitefiber Inc is a provider of artificial intelligence infrastructure solutions. The company owns high-performance computing data centers and provide cloud-based HPC graphics processing units services, which it terms cloud services, for customers such as AI application and machine learning developers. Its Tier-3 data centers provide hosting and colocation services. Its cloud services support generative AI workstreams, especially training and inference. It has two reportable segments: cloud services and colocation services. The cloud services segment generates revenue from providing high performance computing services to support generative AI workstreams. Colocation services generate revenue by providing customers with physical space, power and cooling within the data center facility.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: